[ad_1]
The American pharmaceutical company Moderna will charge governments between $ 25 and $ 37 for a dose of the COVID-19 vaccine, depending on the quantity requested, the company’s chief executive, Stephane Bancel, told the German weekly Welt am Sonntag on Saturday. . .
“In conclusion, our vaccine costs roughly the same as a flu vaccine, which costs between $ 10 and $ 50,” said Moderna’s CEO, according to Agerpres.
Earlier this week, a European official involved in talks with vaccine manufacturers said the EU executive would like to strike a deal with Moderna to provide several million doses of its vaccine at a price of less than $ 25 per one dose.
“We have not signed anything yet, but we are close to an agreement with the European Commission. We want to supply vaccines to Europe and we are involved in constructive discussions, “said Stephane Bancel, adding that it is” a matter of days “until the contract is ready.
Moderna claims that the vaccine it has developed has an efficiency of 94.5%, according to the results of the last stage of clinical trials (phase three), becoming the second vaccine manufacturer to announce results beyond expectations, after Pfizer-BioNTech.
On Thursday, European Commission President Ursula von der Leyen said the European Union could give the green light in mid-December to vaccines developed by Moderna and Pfizer / BioNTech.
The European Medicines Agency (EMA) is in “daily talks” with its US counterpart, the FDA, to “synchronize their evaluations of COVID-19 vaccines,” Ursula von der Leyen said at a press conference.
“If all procedures go smoothly, the EMA could grant conditional marketing authorizations for the Pfizer / BioNTech and Moderna vaccines from the second half of December,” said the EU executive director.
So far, the European Commission has signed five pre-order contracts for potential vaccines with AstraZenaca, Johnson & Johnson, Sanofi-GSK, Pfizer / BioNTech, and CureVac.
Publisher: GC
